Make a note!
$Inhibikase Therapeutics(IKT.US$ Inhibikase Therapeutics - Upon Completion of Double-Blinded Phase of 201 Trial, We Expect to Request an End of Phase 2 Meeting With FDA by End of 2024
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Jaguar8 : Love this!
TrytosaveabitOP Jaguar8: Yup yup! I kinda dig it as well!
taijahmed75 TrytosaveabitOP: do you know any reason for the big fall today? Such a good stock….
TrytosaveabitOP taijahmed75: Im guessing it because they said to shareholders Friday there is a big concern whether they will have enough money to continue
taijahmed75 TrytosaveabitOP: Oh ok, thank you
TrytosaveabitOP taijahmed75: You’re welcome! GL